BioStrand

BioStrand, a subsidiary of ImmunoPrecise Antibodies (IPA), operates at the intersection of biotech, life science, (bio)informatics, and AI. They provide innovative genomic analysis solutions, empowering researchers to unleash the full potential of omics data. Their patented LENSai™ Integrated Intelligence Technology, powered by HYFTs®, seamlessly integrates massive data from diverse sources, providing comprehensive insights that are designed to accelerate drug discovery while maintaining the highest scientific standards.